Mar 4, 2022 This Week in Cardiology
This Week in Cardiology
Medscape Podcasts
4.9 β’ 963 Ratings
ποΈ 4 March 2022
β±οΈ 23 minutes
ποΈ Recording | iTunes | RSS
π§ΎοΈ Download transcript
Summary
An update to CardioMEMs post, ARBs and cancer, troponins, empagliflozin, and low-value care are the topics discussed by John Mandrola, MD, in this week's podcast.
This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic
I β Invasive Monitoring for HF
- FDA Expands Eligibility for CardioMEMS Heart Failure System https://www.medscape.com/viewarticle/969004
- Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial https://doi.org/10.1016/S0140-6736(21)01754-2
II β ARBs and Cancer
- ARBs and Cancer Risk: New Meta-Analysis Raises Questions Again https://www.medscape.com/viewarticle/969510
- Risk of cancer with angiotensin-receptor blockers increases with increasing cumulative exposure: Meta-regression analysis of randomized trials https://doi.org/10.1371/journal.pone.0263461
- Marciniak Meta-analysis in FDA Medical Review 206316Orig1Orig2s000 https://rb.gy/myhlvy
III β Troponins and Cardiac Surgery
- What Troponin Level Indicates Injury After Cardiac Surgery? https://www.medscape.com/viewarticle/969617?src=
- High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality https://www.nejm.org/doi/full/10.1056/NEJMoa2000803
- Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease https://www.nejm.org/doi/full/10.1056/nejmoa1909406
IV β Empagliflozin in HFpEF
- FDA Okays Empagliflozin for HF Regardless of Ejection Fraction https://www.medscape.com/viewarticle/969118
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction https://www.nejm.org/doi/full/10.1056/NEJMoa2107038
- Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction https://www.nejm.org/doi/full/10.1056/NEJMoa1908655
V β Low-Value Care
- AHA Targets 'Low-Value' Heart Care in New Scientific Statement https://www.medscape.com/viewarticle/969107
- Strategies to Reduce Low-Value Cardiovascular Care: A Scientific Statement From the American Heart Association https://www.ahajournals.org/doi/abs/10.1161/HCQ.0000000000000105
You may also like:
Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https://www.medscape.com/features/public/machine
The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net
Transcript
Click on a timestamp to play from that location
| 0:00.0 | You're listening to this week in cardiology from the heart |
| 0:03.4 | org medscape cardiology this podcast is intended for health care |
| 0:07.6 | professionals only any views expressed are the presenters own and do not |
| 0:11.2 | necessarily reflect the views of WebMD or Medscape. |
| 0:15.1 | You can now access the latest in medical news on your Amazon Alexa-enabled device. |
| 0:19.7 | Join me, Perry Wilson, every weekday morning for Medscape Medical Minute where I |
| 0:23.7 | highlight the top medical stories of the day. To add Medscape Medical |
| 0:27.4 | Minute to your flash briefing search for Medscape Medical Minute on Amazon |
| 0:31.1 | and click enable or open the Amazon Alexa app go to skills |
| 0:34.7 | search for Medscape Medical Minute and click enable then say Alexa what's the |
| 0:40.1 | news or Alexa what's my flash briefing I hope you'll join us. |
| 0:44.0 | Hi everyone this is John Mandrola from the heart |
| 0:47.4 | dot org medscape cardiology and this is this week in cardiology for March 4th, 2022. |
| 0:55.0 | This week, I want to update my cardio mems post from last week, |
| 1:00.0 | ARBs and cancer, TRPONNs, |
| 1:03.4 | Eplacloflosing, and low-value care. |
| 1:08.0 | First, an update to my cardio mems post |
| 1:11.2 | from last week. |
| 1:13.1 | Last week I presented on the Guide HF trial |
| 1:16.2 | and how it led to Cardio Mem's FDA approval. |
| 1:20.6 | I strongly oppose the approval. Today I want to give a brief update on something that I did not make clear in that discussion. |
| 1:28.0 | Now if you haven't listened to last week it would be useful now to go back and listen to the first 10 minutes. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Medscape Podcasts, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Medscape Podcasts and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright Β© Tapesearch 2026.

